Biotech companies can skyrocket in a short period because of excellent clinical or regulatory progress. And if we take the ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...

Thus, the development of a system based on the CRISPR/Cas9 genetic scissors, which garnered a Nobel Prize in Chemistry in 2020, made possible the creation of two functional mutants of two of the ...

Now, two women have won the 2020 Nobel Prize in Chemistry “for developing a method for genome editing”. Emmanuelle Charpentier and Jennifer Doudna leveraged CRISPR into a pair of genetic ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. Exa-cel could represent a ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

Casgevy was the first drug to be licensed based on CRISPR, which earned its discoverers a Nobel Prize in 2020. The one-shot therapy is an ex vivo application of the technology, meaning that bone ...

Potatoes are being gene-edited to resist fungi in the warm, wet Peruvian Andes. Sorghum is being taught to resist parasitic ...

This achievement follows Bahrain’s landmark decision on 2 December 2023 to become the second country globally and the first ...

A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...

Casgevy, also known as exa-cel, was the first treatment to be licensed using gene-editing tool Crispr, which earned its inventors the Nobel Prize for chemistry in 2020. It works by editing the fau ...